Feature | April 24, 2012

Researchers Find Little Cancer Risk From CT Scans in Medicare Population

April 24, 2012 — The secondary cancer risk from multi-detector computed tomography (MDCT) scans is low among older adults, according to a study from Stanford University in the April issue of the Journal of the American College of Radiology. A high-speed imaging technique, MDCT is commonly used to diagnose a variety of diseases and conditions. 

Evidence shows that MDCT scanning offers important benefits through more accurate diagnosis and better disease management in a range of medical disorders. However, in the era of MDCT, it has been hypothesized that 1.5 percent to two percent of all cancers may be caused by CT-induced radiation.

“Our study estimates the number of excess cancers due to ionizing radiation in elderly adults. Seniors harbor most diseases that typically rely on CT scanning for diagnosis and management, and therefore receive the highest exposure to CT imaging. What our study found is that the risk of developing a secondary cancer from these CT scans may potentially be lower than previously thought,” said Aabed Meer, author of the study.

A retrospective cohort study was conducted using Medicare claims spanning eight years to assess CT use. The data were analyzed in two four-year cohorts, from 1998 to 2001 and 2002 to 2005. The number and types of CT scans each patient received over the four-year periods were analyzed to determine the percentage of patients exposed to threshold radiation of 50 to 100 mSv (defined as low) and >100 mSv (defined as high). The National Research Council’s Biological Effects of Ionizing Radiation VII models were used to estimate the number of radiation-induced cancers.

“Combining both low-risk and high-risk patient groups (50-100 and >100 mSv), as well as those who received <50 mSv, we estimate that 1,659 cases of cancer (0.03 percent of the study population) will develop in the 1998 to 2001 cohort and 2,185 (0.04 percent of the study population) in the 2002 to 2005 cohort,” said Meer.

CT scans of the head were the most common examinations in both Medicare cohorts, but abdominal imaging delivered the greatest proportion (43 percent in the first cohort and 40 percent in the second cohort) of radiation.

“Although modern CT imaging is a vital part of medical care, its utilization must include a conscious acknowledgment of radiation exposure and an awareness of the pursuant carcinogenic risk. As medical care continues its dependence on advanced technologies such as MDCT, we emphasize the importance of continuing research that encourages the exploration of lower radiation dose technologies,” said Meer.

For more information: www.jacr.org

Related Content

Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Hitachi Supria True64 CT Receives FDA Clearance
Technology | Computed Tomography (CT)| September 15, 2017
Hitachi Healthcare Americas Inc. announced it has attained U.S. Food and Drug Administration (FDA) 510(k) clearance to...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Overlay Init